Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 3 1

Status

Completed 4Active not recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 2Breast 2Gynecologic 1

Conditions

Colorectal Neoplasms 2Breast Neoplasms 2Ovarian Cancer Recurrent 1

Interventions

Cisplatin 1519Carboplatin 1420Cyclophosphamide 1360Gemcitabine 1235Bevacizumab 1226Paclitaxel 1211Radiotherapy 1176Docetaxel 1080pembrolizumab 1028Oxaliplatin 936Capecitabine 901Fluorouracil 833Rituximab 729Doxorubicin 683Nivolumab 679Dexamethasone 666Etoposide 660Irinotecan 622Leucovorin 575Pemetrexed 510Drug Therapy 493Cetuximab 483Trastuzumab 469Cytarabine 466Magnetic Resonance Spectroscopy 458Filgrastim 446Prednisone 433Lenalidomide 409Specimen Handling 408Temozolomide 400

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Tocotrienols × Clear all
NCT04245865 2026-04-03

Toco-CoR

Vejle Hospital

Phase 2 Active not recruiting
83 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT04175470 2025-01-03

Bevacizumab and Tocotrienol in Recurrent Ovarian Cancer

Vejle Hospital

Phase 2 Completed
20 enrolled
Gynecologic

Ovarian Cancer Recurrent

NCT02705300 2024-08-29

Side Effects to FOLFOXIRI + Tocotrienol/Placebo as First Line Treatment of Metastatic Colorectal Cancer

Vejle Hospital

Phase 2 Completed
70 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT02909751 2021-05-20

NeoToc

Vejle Hospital

Phase 2 Completed
80 enrolled
Breast

Breast Neoplasms

NCT04496492 2020-08-03

TOCANNATO

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Completed
50 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡